Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-18-022788)

Filing Details

Accession Number:: 0001127602-18-022788
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-05 11:29:51
Reporting Period:: 2018-07-02

Accepted Time:: 2018-07-05 11:29:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100682	Charles River Laboratories International Inc	CRL	Services-Commercial Physical & Biological Research (8731)	061397316

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1141722	C James Foster	251 Ballardvale Street Wilmington MA 01887	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-07-02	6	$111.45	274,445	No	4	S	Direct
Common Stock	Disposition	2018-07-02	200	$111.46	274,245	No	4	S	Direct
Common Stock	Disposition	2018-07-02	129	$111.47	274,116	No	4	S	Direct
Common Stock	Disposition	2018-07-02	355	$111.48	273,761	No	4	S	Direct
Common Stock	Disposition	2018-07-02	205	$111.49	273,556	No	4	S	Direct
Common Stock	Disposition	2018-07-02	293	$111.50	273,263	No	4	S	Direct
Common Stock	Disposition	2018-07-02	200	$111.53	273,063	No	4	S	Direct
Common Stock	Disposition	2018-07-02	200	$111.54	272,863	No	4	S	Direct
Common Stock	Disposition	2018-07-02	200	$111.57	272,663	No	4	S	Direct
Common Stock	Disposition	2018-07-02	200	$111.58	272,463	No	4	S	Direct
Common Stock	Disposition	2018-07-02	275	$111.59	272,188	No	4	S	Direct
Common Stock	Disposition	2018-07-02	100	$111.61	272,088	No	4	S	Direct
Common Stock	Disposition	2018-07-02	112	$111.63	271,976	No	4	S	Direct
Common Stock	Disposition	2018-07-02	200	$111.68	271,776	No	4	S	Direct
Common Stock	Disposition	2018-07-02	100	$111.69	271,676	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,208	Indirect	2016 GRAT
Common Stock	29,954	Indirect	2017 GRAT
Common Stock	340	Indirect	By Trust
Common Stock	10,000	Indirect	Held By Spouse

Footnotes

This sale occurred pursuant to a 10b5-1 Trading Plan.